156 related articles for article (PubMed ID: 10561281)
1. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.
Herman EH; Zhang J; Lipshultz SE; Rifai N; Chadwick D; Takeda K; Yu ZX; Ferrans VJ
J Clin Oncol; 1999 Jul; 17(7):2237-43. PubMed ID: 10561281
[TBL] [Abstract][Full Text] [Related]
2. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
[TBL] [Abstract][Full Text] [Related]
3. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
Herman EH; Zhang J; Rifai N; Lipshultz SE; Hasinoff BB; Chadwick DP; Knapton A; Chai J; Ferrans VJ
Cancer Chemother Pharmacol; 2001 Oct; 48(4):297-304. PubMed ID: 11710630
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.
Zhang J; Knapton A; Lipshultz SE; Cochran TR; Hiraragi H; Herman EH
Toxicol Pathol; 2014; 42(2):361-75. PubMed ID: 23531790
[TBL] [Abstract][Full Text] [Related]
5. Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats.
Herman E; Zhang J; Knapton A; Lipshultz SE; Rifai N; Sistare F
Cardiovasc Toxicol; 2006; 6(3-4):211-22. PubMed ID: 17347531
[TBL] [Abstract][Full Text] [Related]
6. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.
Kismet E; Varan A; Ayabakan C; Alehan D; Portakal O; Büyükpamukçu M
Pediatr Blood Cancer; 2004 Mar; 42(3):220-4. PubMed ID: 14752858
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
Adamcová M; Šimůnek T; Kaiserová H; Popelová O; Štěrba M; Potáčová A; Vávrová J; Maláková J; Geršl V
Toxicology; 2007 Jul; 237(1-3):218-228. PubMed ID: 17587482
[TBL] [Abstract][Full Text] [Related]
8. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.
Herman EH; el-Hage AN; Ferrans VJ; Ardalan B
Toxicol Appl Pharmacol; 1985 Apr; 78(2):202-14. PubMed ID: 4035676
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings.
Bertinchant JP; Polge A; Juan JM; Oliva-Lauraire MC; Giuliani I; Marty-Double C; Burdy JY; Fabbro-Peray P; Laprade M; Bali JP; Granier C; de la Coussaye JE; Dauzat M
Clin Chim Acta; 2003 Mar; 329(1-2):39-51. PubMed ID: 12589964
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
12. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
[TBL] [Abstract][Full Text] [Related]
13. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
Takashio S; Yamamuro M; Uemura T; Utsunomiya D; Morita K; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Yasuda O; Yamashita Y; Ogawa H
Am J Cardiol; 2014 May; 113(10):1697-704. PubMed ID: 24698466
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity.
Reagan WJ; York M; Berridge B; Schultze E; Walker D; Pettit S
Toxicol Pathol; 2013; 41(8):1146-58. PubMed ID: 23531791
[TBL] [Abstract][Full Text] [Related]
15. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
[TBL] [Abstract][Full Text] [Related]
16. [Plasma levels of troponin T in rabbits after administration of new antineoplastic agents (Oracin and Dimefluron) and daunorubicin].
Adamcová M; Machácková J; Gersl V; Hrdina R; Mazurová Y; Mĕlka M; Nobilis M
Acta Medica (Hradec Kralove) Suppl; 2001; 44(1):3-8. PubMed ID: 11892362
[TBL] [Abstract][Full Text] [Related]
17. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits.
Adamcová M; Gersl V; Hrdina R; Melka M; Mazurová Y; Vávrová J; Palicka V; Kokstein Z
J Cancer Res Clin Oncol; 1999; 125(5):268-74. PubMed ID: 10359131
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Effects of Liraglutide, Oxytocin and Granulocyte Colony-Stimulating Factor in Doxorubicin-Induced Cardiomyopathy Model: An Experimental Animal Study.
Taşkıran E; Erdoğan MA; Yiğittürk G; Erbaş O
Cardiovasc Toxicol; 2019 Dec; 19(6):510-517. PubMed ID: 31054117
[TBL] [Abstract][Full Text] [Related]
19. Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury.
Zhang J; Knapton A; Lipshultz SE; Weaver JL; Herman EH
Toxicol Pathol; 2008 Feb; 36(2):277-8. PubMed ID: 18349426
[TBL] [Abstract][Full Text] [Related]
20. Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy.
Šramko M; Kubánek M; Tintěra J; Kautznerová D; Weichet J; Malušková J; Franeková J; Kautzner J
Am J Cardiol; 2013 Jan; 111(2):258-64. PubMed ID: 23102878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
